Camel milk against gastrointestinal disorders Camel milk contains a high concentration of antiinflammatory proteins, which have a positive health effect on the stomach and intestinal disorders. The high proportion of mono and polyunsaturated fatty acids and vitamin-rich composition provide improved carbohydrate metabolism (Karray et al., 2005; Konuspayeva et al., 2008). Moreover, it was found that fermented camel milk has an enzyme (Angiotensin I-converting enzyme, ACE) (Quan et al., 2008), which facilitates the digestion of the milk proteins (Alhaj et al., 2006). Recent reports on the application of camel milk for the health of the digestive system showed that camel milk has anti-diarrhea-properties and all children, who have taken camel milk and with the 20 bouts of diarrhea per day are cured with normal bowel movements (Yagil, 2013). Camel milk can also be used in small children who have diarrhea by food contamination with rotavirus, because camel milk is rich in anti-rotavirus antibodies (Yagil, 2013).

Experiments were designed to investigate the suitability of a combination of a short manual teat stimulation with a short latency period before teat cup attachment to induce and maintain oxytocin release and milk ejection without interruption. In Experiment 1, seven dairy cows in mid lactation were manually pre-stimulated for 15, 30 or 45 s, followed by either 30 s or 45 s of latency period. It was shown that all treatments induced a similar release of oxytocin without interruption until the end of milking. In particular, the latency period of up to 45 s did not cause a transient decrease of oxytocin concentration. In Experiment 2, milking characteristics were recorded in seven cows each in early, mid, and late lactation, respectively. Because the course of milk ejection depends mainly on the degree of udder filling, individual milkings were classified based on the actual degree of udder filling which differs between lactational stages but also between morning and evening milkings. All animals underwent twelve different udder preparation treatments, i.e. 15, 30, or 45 s of pre-stimulation followed by latency periods of 0, 30, 45, or 60 s. Milking characteristics were recorded. Total milk yield, main milking time and average milk flow rate did not differ between treatments if the degree of udder filling at the start of milking was > 40% of the maximum storage capacity. However, if the udder filling was < 40%, main milking time was decreased with the duration of a latency period up to 45 s, independent of duration of pre-stimulation. Average milk flow at an udder filling of < 40% was highest after a pre-stimulation of 45 s followed by a latency period of another 45 s. In contrast, average milk flow reached its lowest values at a pre-stimulation of 15 s without additional latency period. However, average milk flow after a 15-s pre-stimulation increased with increasing latency period. In conclusion, a very short pre-stimulation when followed by a latency period up to 45 s before teat cup attachment remains a suitable alternative for continuous stimulation to induce milk ejection.

Milk proteins are a heterogeneous group of polymeric compounds that have a wide range of different molecular structures and properties. They occur as caseins, whey proteins, enzymes, minor proteins and nitrogen compounds. Caseins constitute about 80% of the total proteins of cow’s milk. β-casein is an important part of the caseins, which makes up about 37% of the total caseins. Within β-casein, there are a number of variants which are genetically determined. However, there are thirteen genetic variants of β-casein found in cow´s milk. A1 and A2 are the most common variants, which are called A1 β-casein (A1-milk) and A2 β-casein (A2-milk). The only difference between A1- and A2-milk is a difference in the 67th amino acid in the chain. At this position, A2-milk has a proline amino acid, while A1-milk has histidine amino acid. Several studies have reported that cow’s milk with a dominant or singular A2-milk may be healthier than A1-milk. These studies are based on digestion of A1-milk which lead to release β-casomorphin-7 (BCM-7). Subsequently increase inflammation, Type-1-diabetes, heart disease, autism, gastrointestinal discomfort and other disease in the consumer. For this reason, there is a growing global interest in A2-milk. In conclusion, the effects of A1-milk compared to A2-milk on human health show mixed results. On the basis of the available results, we cannot conclusively assess the health effects of A1-milk and A2-milk. Therefore, further investigations are needed.

No abstract

No abstract